Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P52429

Entry ID Method Resolution Chain Position Source
AF-P52429-F1 Predicted AlphaFoldDB

472 variants for P52429

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV001328196
rs1906465563
1 M>L Atypical hemolytic-uremic syndrome [ClinVar] Yes ClinVar
dbSNP
COSM706760
RCV000043570
RCV000122612
rs148605410
CA143787
11 S>* lung Atypical hemolytic-uremic syndrome Hemolytic uremic syndrome, atypical, susceptibility to, 7 [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
ESP
dbSNP
RCV000268794
CA8663407
RCV000949004
rs146866423
RCV002294220
12 P>L Kidney disorder [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000965392
RCV002294425
rs73994915
CA8663415
20 G>E Kidney disorder [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000032778
rs398123008
CA130373
43 Q>* Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1482608926
RCV000625636
CA399921308
60 H>D Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs312262694
VAR_069804
RCV000043569
CA143786
63 R>P Hemolytic uremic syndrome, atypical, susceptibility to, 7 AHUS7 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV001280928
RCV002480930
CA399921555
rs775804689
78 A>G Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA399921914
rs777787526
RCV000515466
101 K>* Atypical hemolytic-uremic syndrome [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs201209316
CA8663470
RCV002546672
RCV002546671
RCV001334158
101 K>N Inborn genetic diseases Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1906529223
RCV001250397
150 K>missing Hemolytic uremic syndrome, atypical, susceptibility to, 1 [ClinVar] Yes ClinVar
dbSNP
RCV000122613
rs312262698
158 W>missing Atypical hemolytic-uremic syndrome [ClinVar] Yes ClinVar
dbSNP
RCV000043568
rs312262699
RCV000122614
163 V>missing Atypical hemolytic-uremic syndrome Hemolytic uremic syndrome, atypical, susceptibility to, 7 [ClinVar] Yes ClinVar
dbSNP
rs147972030
RCV001849287
RCV000032779
RCV002294380
RCV000786909
204 T>missing Nephrotic syndrome Atypical hemolytic-uremic syndrome Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinVar
dbSNP
rs1064797074
RCV000487442
242 I>* Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinVar
dbSNP
RCV000122615
RCV000043571
CA143789
rs312262695
VAR_069805
273 R>P Atypical hemolytic-uremic syndrome Hemolytic uremic syndrome, atypical, susceptibility to, 7 AHUS7 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
RCV001201397
rs749415630
314 N>K Hemolytic uremic syndrome, atypical, susceptibility to, 1 [ClinVar] Yes ClinVar
dbSNP
RCV000122617
rs138924661
RCV000760165
CA332175
RCV001854681
RCV000043567
322 W>* Atypical hemolytic-uremic syndrome Hemolytic uremic syndrome, atypical, susceptibility to, 7 Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001334159
RCV002546673
rs1907467218
332 V>A Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinVar
dbSNP
CA332170
RCV000122611
rs312262697
334 Q>* Atypical hemolytic-uremic syndrome [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs762576212
RCV000625635
CA8663663
337 R>* Variant assessed as Somatic; 0.0 impact. Immunoglobulin-mediated membranoproliferative glomerulonephritis [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs1060499709
CA16609459
RCV000449615
390 R>H Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA16609460
RCV000449567
rs1060499708
459 W>* Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1567825026
RCV000786908
482 V>missing Immunoglobulin-mediated membranoproliferative glomerulonephritis [ClinVar] Yes ClinVar
dbSNP
CA399920172
rs1227124891
3 A>P No ClinGen
gnomAD
TCGA novel 3 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs765790817
CA8663399
4 E>* No ClinGen
ExAC
gnomAD
rs1323818712
CA399920211
5 R>K No ClinGen
TOPMed
rs750899526
CA8663400
7 P>A No ClinGen
ExAC
gnomAD
rs1486518180
CA399920280
7 P>L No ClinGen
gnomAD
CA399920271
rs750899526
7 P>S No ClinGen
ExAC
gnomAD
CA399920307
rs752026075
8 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA8663403
rs752026075
8 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA399920320
rs1464525023
9 P>A No ClinGen
gnomAD
CA8663405
rs777447868
10 G>A No ClinGen
ExAC
gnomAD
CA8663404
rs555438585
10 G>S No ClinGen
1000Genomes
ExAC
gnomAD
CA291896844
rs148605410
11 S>W No ClinGen
ESP
CA399920400
rs1392043399
12 P>A No ClinGen
TOPMed
gnomAD
CA291896849
rs914721678
13 S>C No ClinGen
TOPMed
CA399920523
rs1385761640
14 E>G No ClinGen
gnomAD
rs915669267
CA291896868
14 E>K No ClinGen
TOPMed
gnomAD
CA291896875
rs915669267
14 E>Q No ClinGen
TOPMed
gnomAD
CA399920558
rs1433746703
15 G>V No ClinGen
gnomAD
CA8663411
rs775145361
16 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs1317914274
CA399920625
17 F>L No ClinGen
gnomAD
CA399920616
rs1301085394
17 F>S No ClinGen
gnomAD
TCGA novel 19 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA291896879
rs373335233
CA399920711
20 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663414
rs373335233
20 G>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663416
rs765244770
21 H>L No ClinGen
ExAC
gnomAD
rs1266323191
CA399920788
22 L>Q No ClinGen
gnomAD
CA291896886
rs938951070
22 L>V No ClinGen
TOPMed
gnomAD
rs773398906
CA8663417
23 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1409732128
CA399920825
24 L>S No ClinGen
TOPMed
gnomAD
CA8663419
rs766947676
25 W>R No ClinGen
ExAC
gnomAD
CA8663420
rs375106157
26 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
rs1351245490
CA399920862
27 L>V No ClinGen
gnomAD
rs1352363942
CA399920876
28 C>R No ClinGen
TOPMed
CA399920891
rs1433783652
28 C>W No ClinGen
gnomAD
CA399920898
rs1374447524
29 S>* No ClinGen
gnomAD
CA291896907
rs910010207
29 S>A No ClinGen
gnomAD
CA399920900
rs1374447524
29 S>L No ClinGen
gnomAD
CA399920899
rs1374447524
29 S>W No ClinGen
gnomAD
rs759913694
CA8663421
30 V>I No ClinGen
ExAC
gnomAD
rs376469683
CA8663422
33 P>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA399920988
rs1598010433
34 V>G No ClinGen
Ensembl
rs756703489
CA8663424
34 V>L No ClinGen
ExAC
gnomAD
rs1184132450
CA399921038
38 F>S No ClinGen
TOPMed
gnomAD
rs1184132450
CA399921037
38 F>Y No ClinGen
TOPMed
gnomAD
CA8663427
rs201377251
39 W>C No ClinGen
1000Genomes
ExAC
gnomAD
CA399921098
rs780090113
41 S>I No ClinGen
ExAC
TOPMed
gnomAD
CA8663428
rs780090113
41 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs746752889
CA8663429
42 L>F No ClinGen
ExAC
gnomAD
TCGA novel 42 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs746752889
CA399921107
42 L>V No ClinGen
ExAC
gnomAD
rs781507429
COSM561650
CA8663431
44 R>Q lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA399921153
rs1598010533
45 S>A No ClinGen
Ensembl
rs1163604709
CA399921166
46 R>C No ClinGen
gnomAD
CA399921184
rs748367577
47 R>L No ClinGen
ExAC
gnomAD
CA8663432
rs748367577
47 R>Q No ClinGen
ExAC
gnomAD
rs773132460
CA8663434
48 Q>* No ClinGen
ExAC
gnomAD
rs773132460
CA399921190
48 Q>K No ClinGen
ExAC
gnomAD
rs1350263987
CA399921252
52 R>K No ClinGen
gnomAD
rs558221360
CA291896988
53 D>H No ClinGen
1000Genomes
gnomAD
rs1567806847
CA399921272
55 F>L No ClinGen
Ensembl
rs373991932
CA8663437
56 R>C No ClinGen
ESP
ExAC
gnomAD
rs759825918
CA8663438
56 R>L No ClinGen
ExAC
gnomAD
rs1272143279
CA399921294
58 S>N No ClinGen
gnomAD
TCGA novel 58 S>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753122117
CA8663440
60 H>R No ClinGen
ExAC
gnomAD
CA399921309
rs1482608926
60 H>Y No ClinGen
gnomAD
rs764983358
CA8663442
61 G>R No ClinGen
ExAC
gnomAD
rs764983358
CA8663443
COSM120120
61 G>W ovary Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA399921318
rs1598010725
62 W>G No ClinGen
Ensembl
rs368624469
CA8663446
63 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663445
rs368624469
63 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA399921337
rs1450878792
64 D>E No ClinGen
gnomAD
rs1402720870
CA399921339
65 T>A No ClinGen
gnomAD
CA291897027
rs998811612
67 L>P No ClinGen
Ensembl
CA8663449
rs747995629
69 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs781129488
CA8663448
69 S>T No ClinGen
ExAC
gnomAD
CA8663450
rs769882986
71 P>L No ClinGen
ExAC
gnomAD
rs1462738297
CA399921474
73 Y>* No ClinGen
TOPMed
gnomAD
CA399921469
rs1284436449
73 Y>C No ClinGen
TOPMed
rs749284912
CA8663453
75 C>S No ClinGen
ExAC
gnomAD
CA8663455
rs562198537
75 C>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs760028073
CA8663456
76 V>A No ClinGen
ExAC
gnomAD
rs1341139463
CA399921517
76 V>L No ClinGen
gnomAD
rs1313592332
CA399921532
77 C>R No ClinGen
TOPMed
CA8663457
rs772637651
78 A>T No ClinGen
ExAC
gnomAD
rs775804689
CA8663458
78 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA8663459
rs143468147
79 Q>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA291897114
rs773920210
81 I>M No ClinGen
gnomAD
CA291897133
rs879047850
83 Q>* No ClinGen
Ensembl
CA8663462
rs762304023
85 A>V No ClinGen
ExAC
gnomAD
CA399921721
rs1423669427
88 D>Y No ClinGen
gnomAD
CA399921763
rs1160481595
90 C>R No ClinGen
gnomAD
CA399921788
rs1320120680
91 G>E No ClinGen
gnomAD
CA8663465
CA399921781
rs754934356
91 G>R No ClinGen
ExAC
gnomAD
CA399921801
rs1404587799
93 R>C No ClinGen
TOPMed
CA399921798
rs1404587799
93 R>S No ClinGen
TOPMed
TCGA novel 96 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1342618191
CA399921865
97 G>R No ClinGen
gnomAD
rs1268716733
CA399921893
99 L>F No ClinGen
gnomAD
VAR_036120 99 L>R a breast cancer sample; somatic mutation [UniProt] No UniProt
CA399921910
rs969844522
100 R>S No ClinGen
TOPMed
rs777787526
CA8663469
101 K>E No ClinGen
ExAC
TOPMed
gnomAD
rs1242360342
CA399921937
102 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA8663471
rs757482556
103 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA291897186
rs200324699
104 K>R No ClinGen
1000Genomes
ESP
TOPMed
gnomAD
CA399921968
rs1200565530
105 R>C No ClinGen
gnomAD
CA399921970
rs1245283449
105 R>H No ClinGen
gnomAD
CA8663473
rs745990961
106 F>L No ClinGen
ExAC
gnomAD
CA8663474
rs201997595
106 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 106 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399922053
rs1455705467
109 K>R No ClinGen
gnomAD
CA291897210
rs915029037
110 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1395324030
CA399922139
112 M>I No ClinGen
gnomAD
rs1407222746
CA399922147
113 L>F No ClinGen
gnomAD
rs776001127
CA8663475
114 K>E No ClinGen
ExAC
gnomAD
CA291897215
rs564611390
114 K>R No ClinGen
Ensembl
rs747298055
CA399922188
115 N>D No ClinGen
ExAC
gnomAD
CA8663476
rs747298055
115 N>H No ClinGen
ExAC
gnomAD
CA399922198
rs1435559196
115 N>S No ClinGen
gnomAD
CA399922234
rs1270817942
116 D>E No ClinGen
TOPMed
CA399922224
rs1364127172
116 D>G No ClinGen
TOPMed
rs148908859
CA399922248
117 T>I No ClinGen
ESP
TOPMed
gnomAD
rs148908859
CA291897219
117 T>S No ClinGen
ESP
TOPMed
gnomAD
rs1266875850
CA399922320
119 V>A No ClinGen
TOPMed
gnomAD
rs762662843
CA8663479
119 V>I No ClinGen
ExAC
CA399922407
rs1270244894
123 M>I No ClinGen
gnomAD
rs767519633
CA8663483
123 M>V No ClinGen
ExAC
gnomAD
CA399922433
rs1567807426
125 H>R No ClinGen
Ensembl
rs938904565
CA291897277
126 H>Y No ClinGen
TOPMed
rs1488289743
CA399922463
127 W>* No ClinGen
TOPMed
gnomAD
rs1190110291
CA399922473
128 I>M No ClinGen
TOPMed
rs755804606
CA8663486
129 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs752681978
CA8663485
129 R>W No ClinGen
ExAC
gnomAD
CA8663487
rs763932703
131 N>T No ClinGen
ExAC
gnomAD
CA399922509
rs1270507707
132 V>M No ClinGen
TOPMed
rs757444386
CA399922539
135 C>R No ClinGen
ExAC
TOPMed
gnomAD
CA8663489
rs757444386
135 C>S No ClinGen
ExAC
TOPMed
gnomAD
COSM3983560
rs1567807518
CA399922575
137 Y>* ovary [Cosmic] No ClinGen
cosmic curated
Ensembl
CA291897307
rs922860341
137 Y>H No ClinGen
Ensembl
CA8663490
rs779158220
138 C>R No ClinGen
ExAC
gnomAD
rs1407848078
CA399922591
139 M>V No ClinGen
gnomAD
rs745902152
CA8663491
142 K>R No ClinGen
ExAC
gnomAD
CA399922648
rs1340500871
143 Q>E No ClinGen
gnomAD
CA399922673
rs1273869243
144 Q>R No ClinGen
TOPMed
rs758506570
CA8663492
145 C>Y No ClinGen
ExAC
gnomAD
CA399922746
rs1598011601
147 C>W No ClinGen
Ensembl
rs1355274902
CA399922735
147 C>Y No ClinGen
gnomAD
CA8663494
rs747565175
149 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA8663495
rs769109284
150 K>M No ClinGen
ExAC
gnomAD
rs946844153
CA291897323
152 C>S No ClinGen
TOPMed
gnomAD
CA291897324
rs767517741
153 D>E No ClinGen
Ensembl
CA399922858
rs1425598376
153 D>G No ClinGen
gnomAD
rs777022657
CA8663496
153 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs748508357
CA8663497
154 Y>C No ClinGen
ExAC
gnomAD
CA399922899
rs1450264268
155 R>G No ClinGen
gnomAD
rs1267736533
CA399925936
162 T>P No ClinGen
gnomAD
TCGA novel 162 T>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1434704796
CA399925948
164 H>N No ClinGen
gnomAD
CA291904463
rs970785170
165 D>H No ClinGen
TOPMed
rs759994160
CA8663521
165 D>V No ClinGen
ExAC
gnomAD
rs966154306
CA399925982
166 E>D No ClinGen
gnomAD
rs1428563626
CA399925971
166 E>K No ClinGen
gnomAD
CA399925991
rs1160817377
167 C>Y No ClinGen
gnomAD
rs1293783964
CA399926017
168 M>I No ClinGen
TOPMed
gnomAD
CA291904504
rs867685255
168 M>T No ClinGen
gnomAD
TCGA novel 170 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1244150953
CA399926055
171 S>N No ClinGen
TOPMed
gnomAD
rs1181441429
CA399926120
175 E>A No ClinGen
TOPMed
gnomAD
TCGA novel 176 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs926471081
CA291904559
178 D>G No ClinGen
TOPMed
rs200696523
CA291904539
178 D>Y No ClinGen
1000Genomes
gnomAD
rs1351720702
CA399926245
183 K>R No ClinGen
gnomAD
CA8663526
rs750278156
187 I>V No ClinGen
ExAC
gnomAD
rs61751969
CA399926311
188 P>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs61751969
CA8663527
188 P>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663528
RCV000788247
rs376400766
190 S>G No ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1267503868
CA399926384
193 T>I No ClinGen
gnomAD
CA8663531
rs781673543
195 I>M No ClinGen
ExAC
TOPMed
CA291904610
rs967017280
195 I>V No ClinGen
TOPMed
CA291904638
rs1047366372
197 Q>* No ClinGen
TOPMed
CA399926441
rs1201131211
197 Q>H No ClinGen
TOPMed
rs753267693
CA399926464
199 R>C No ClinGen
ExAC
gnomAD
rs753267693
CA8663532
199 R>G No ClinGen
ExAC
gnomAD
CA8663533
rs756738955
199 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs778274216
CA8663534
200 K>I No ClinGen
ExAC
gnomAD
CA8663536
rs370201438
201 D>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663535
rs370201438
201 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA399926523
rs1338042777
202 K>Q No ClinGen
TOPMed
TCGA novel 203 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8663539
rs779598425
204 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA8663538
rs779598425
204 T>K No ClinGen
ExAC
TOPMed
gnomAD
rs147972030 204 T>N Variant assessed as Somatic; 5.024e-05 impact. [NCI-TCGA] No NCI-TCGA
rs147972030 204 T>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1418022874
CA399926577
205 D>G No ClinGen
gnomAD
CA399926611
rs1165011956
207 E>G No ClinGen
gnomAD
rs768056634
CA8663540
208 V>A No ClinGen
ExAC
gnomAD
rs1351301690
CA399926616
208 V>M No ClinGen
gnomAD
rs200253169
CA8663566
209 L>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201970745
CA8663568
210 A>S No ClinGen
1000Genomes
ExAC
gnomAD
rs1306910008
CA399926652
211 S>P No ClinGen
gnomAD
rs1238542643
CA399926660
212 K>M No ClinGen
gnomAD
rs1189663693
CA399926668
213 L>H No ClinGen
TOPMed
CA399926674
rs1210748351
214 G>V No ClinGen
gnomAD
CA399926708
rs1443240645
218 T>I No ClinGen
TOPMed
rs1057146710
CA291905762
225 N>S No ClinGen
gnomAD
CA399926799
rs1167165089
226 S>C No ClinGen
gnomAD
rs754404145
CA8663573
227 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA8663574
rs757585573
227 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8663575
rs765508973
228 S>G No ClinGen
ExAC
gnomAD
rs1598027097
CA399926828
229 G>E No ClinGen
Ensembl
rs750866589
CA8663576
229 G>R No ClinGen
ExAC
gnomAD
rs1321430551
CA399926857
231 N>K No ClinGen
TOPMed
gnomAD
TCGA novel 231 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs780844760
CA8663578
232 M>I No ClinGen
ExAC
TOPMed
gnomAD
CA8663577
rs754556879
232 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA399926860
rs1227653538
232 M>V No ClinGen
TOPMed
rs201154049
CA8663580
238 G>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663584
rs778536839
246 P>T No ClinGen
ExAC
gnomAD
rs1356684612
CA399927085
252 V>I No ClinGen
gnomAD
CA399927095
rs1229695028
253 T>I No ClinGen
gnomAD
rs776544681
CA8663612
254 K>E No ClinGen
ExAC
gnomAD
rs1439397970
CA399927102
254 K>N No ClinGen
gnomAD
rs1598030392
CA399927109
255 T>I No ClinGen
Ensembl
rs1490298936
CA399927110
256 P>A No ClinGen
gnomAD
rs1206440405
CA399927115
256 P>L No ClinGen
gnomAD
rs1049451304
CA291907657
257 P>A No ClinGen
TOPMed
gnomAD
CA399927117
rs1049451304
257 P>S No ClinGen
TOPMed
gnomAD
rs943486760
CA291907665
258 I>V No ClinGen
TOPMed
gnomAD
rs770159608
CA8663614
259 K>N No ClinGen
ExAC
gnomAD
rs138464211
CA399927145
262 Q>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs138464211
CA8663618
262 Q>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs138464211
CA8663619
262 Q>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663620
rs763782896
265 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs1423822187
CA399927206
267 L>I No ClinGen
gnomAD
CA8663622
rs539590607
269 Y>* No ClinGen
1000Genomes
ExAC
gnomAD
rs1456664574
CA399927230
269 Y>H No ClinGen
gnomAD
CA8663623
rs765019786
270 Y>H No ClinGen
ExAC
gnomAD
CA399927282
rs750391888
273 R>* No ClinGen
ExAC
TOPMed
gnomAD
rs312262695
CA399927287
273 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs312262695
CA8663625
273 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA8663626
rs374631132
275 L>P No ClinGen
ESP
ExAC
gnomAD
rs1312495887
CA399927314
276 V>F No ClinGen
gnomAD
CA291907786
rs12601812
277 C>* No ClinGen
Ensembl
rs746840886
CA8663627
280 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA8663628
rs755230915
281 G>V No ClinGen
ExAC
gnomAD
rs1337950463
CA399927416
284 G>A No ClinGen
gnomAD
rs748107737
CA8663631
289 A>T No ClinGen
ExAC
gnomAD
rs918863569
CA8663632
290 V>A No ClinGen
Ensembl
rs1181954531
CA399927504
292 D>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs369455582
CA8663634
293 M>L No ClinGen
ESP
ExAC
gnomAD
rs369455582
CA399927517
293 M>V No ClinGen
ESP
ExAC
gnomAD
CA8663635
rs773222196
295 I>F No ClinGen
ExAC
TOPMed
gnomAD
rs773222196
CA291907814
295 I>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 299 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1302582956
CA399927686
300 K>E No ClinGen
gnomAD
TCGA novel 301 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA399927707
rs1222236677
301 Y>F No ClinGen
gnomAD
rs1388160841
CA399927731
303 P>S No ClinGen
TOPMed
rs756357670
CA8663653
304 Q>E No ClinGen
ExAC
gnomAD
CA291908466
rs1038384139
306 A>P No ClinGen
TOPMed
gnomAD
rs777875736
CA8663654
309 P>R No ClinGen
ExAC
gnomAD
rs1204390591
CA399927825
311 G>R No ClinGen
gnomAD
CA399927852
rs1461794172
315 D>H No ClinGen
TOPMed
rs1197224876
CA399927860
316 L>V No ClinGen
gnomAD
CA399927866
rs1472659928
317 S>A No ClinGen
gnomAD
rs1160802291
CA399927874
318 N>S No ClinGen
gnomAD
CA8663657
rs774867964
321 G>C No ClinGen
ExAC
gnomAD
CA291908492
rs200528872
321 G>V No ClinGen
TOPMed
rs746167490
CA8663658
322 W>* No ClinGen
ExAC
gnomAD
CA399927902
rs1403597745
323 G>S No ClinGen
gnomAD
rs1435139148
CA773369855
326 Y>* No ClinGen
TOPMed
CA291908532
rs1029933578
331 P>A No ClinGen
TOPMed
rs149433337
CA8663660
333 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA399927976
rs1305110428
334 Q>H No ClinGen
TOPMed
gnomAD
CA291908578
rs368125102
337 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368125102
COSM561647
CA8663664
337 R>Q lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA399927993
rs1210259742
338 N>H No ClinGen
Ensembl
rs371285031
CA8663665
338 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1268143568
CA399928000
339 V>I No ClinGen
TOPMed
gnomAD
CA291908594
rs1017948303
340 M>V No ClinGen
TOPMed
rs1567816373
CA399928015
341 E>Q No ClinGen
Ensembl
rs752471158
CA8663668
342 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs767338282
CA8663667
342 A>T No ClinGen
ExAC
gnomAD
rs752471158
CA399928024
342 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1405183242
CA399928026
343 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA399928031
rs1430958659
343 D>V No ClinGen
TOPMed
CA399928039
rs1171912851
344 G>V No ClinGen
TOPMed
rs1165081063
CA399928059
347 L>P No ClinGen
gnomAD
rs1418081607
CA399928056
347 L>V No ClinGen
gnomAD
CA8663670
rs777877548
348 D>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
COSM3421721
rs753872019
CA399928068
349 R>* Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA8663673
rs757336402
349 R>L No ClinGen
ExAC
TOPMed
rs757336402
CA399928070
349 R>Q No ClinGen
ExAC
TOPMed
CA291908973
rs200272547
350 W>L No ClinGen
ExAC
gnomAD
CA8663692
rs200272547
350 W>S No ClinGen
ExAC
gnomAD
rs1362438579
CA399928091
351 K>E No ClinGen
gnomAD
CA291908979
rs199990750
352 V>A No ClinGen
1000Genomes
rs750512560
CA8663694
353 Q>K No ClinGen
ExAC
gnomAD
rs1404247469
CA399928124
356 N>Y No ClinGen
TOPMed
gnomAD
rs1030702730
CA291908991
359 Y>H No ClinGen
TOPMed
rs780449140
CA8663697
361 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA8663698
rs780449140
361 N>T No ClinGen
ExAC
TOPMed
gnomAD
CA8663699
rs768908823
362 L>V No ClinGen
ExAC
gnomAD
rs1367992713
CA399928212
364 K>Q No ClinGen
TOPMed
gnomAD
CA8663700
rs74815275
366 K>R No ClinGen
1000Genomes
ExAC
gnomAD
rs751994856
CA8663717
367 E>* No ClinGen
ExAC
gnomAD
TCGA novel 369 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA291877754
rs762791909
369 T>K No ClinGen
Ensembl
CA8663719
rs781661625
370 M>V No ClinGen
ExAC
gnomAD
rs748572065
CA8663720
372 N>S No ClinGen
ExAC
gnomAD
rs756916762
CA8663721
373 Y>H No ClinGen
ExAC
gnomAD
CA291877770
rs142444960
377 G>V No ClinGen
ESP
rs745306422
CA8663723
378 P>R No ClinGen
ExAC
gnomAD
rs1279767089
CA399905587
378 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA399905590
rs1393027709
379 D>N No ClinGen
TOPMed
rs1283942184
CA399905605
381 L>I No ClinGen
gnomAD
CA8663724
rs771492726
381 L>P No ClinGen
ExAC
gnomAD
rs376884670
CA8663725
382 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663726
rs145980200
385 N>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs768623816
CA399905656
388 A>G No ClinGen
ExAC
gnomAD
CA8663727
rs768623816
388 A>V No ClinGen
ExAC
gnomAD
CA8663728
rs776393370
389 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA8663729
rs761618548
390 R>G No ClinGen
ExAC
gnomAD
CA8663731
rs773312573
393 A>S No ClinGen
ExAC
gnomAD
CA291877804
rs551319122
395 S>A No ClinGen
1000Genomes
ExAC
gnomAD
CA8663733
rs551319122
395 S>T No ClinGen
1000Genomes
ExAC
gnomAD
CA399905744
rs1404263029
396 L>V No ClinGen
gnomAD
CA291877807
rs1027342110
398 S>C No ClinGen
TOPMed
gnomAD
CA291877809
rs1027342110
398 S>F No ClinGen
TOPMed
gnomAD
TCGA novel 398 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1439519433
CA399905820
400 R>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA291878440
rs1021695324
405 A>T No ClinGen
Ensembl
CA8663748
rs769591760
405 A>V No ClinGen
ExAC
gnomAD
rs1202033040
CA399906076
406 V>F No ClinGen
gnomAD
CA399906085
rs1598046190
406 V>G No ClinGen
Ensembl
rs1240995764
CA399906119
409 F>L No ClinGen
gnomAD
CA291878449
rs370690011
415 C>S No ClinGen
ESP
TOPMed
gnomAD
rs763052903
CA8663750
417 V>A No ClinGen
ExAC
gnomAD
rs562050880
CA291878455
418 Q>* No ClinGen
gnomAD
rs562050880
CA399906313
418 Q>K No ClinGen
gnomAD
CA291878460
rs966966970
420 C>F No ClinGen
TOPMed
CA8663752
rs774246667
420 C>G No ClinGen
ExAC
gnomAD
CA8663754
rs768067588
426 K>N No ClinGen
ExAC
gnomAD
CA399906841
rs761319737
428 E>D No ClinGen
ExAC
gnomAD
CA8663755
rs753267548
428 E>G No ClinGen
ExAC
gnomAD
rs1419254406
CA399908741
430 E>* No ClinGen
gnomAD
rs546285860
CA291879350
431 L>V No ClinGen
ExAC
gnomAD
rs1362392162
CA399908774
432 D>N No ClinGen
gnomAD
CA291879352
rs887079494
435 R>Q No ClinGen
TOPMed
CA8663786
rs748965902
436 V>A No ClinGen
ExAC
gnomAD
rs1164758538
CA399908867
436 V>I No ClinGen
gnomAD
rs1403641711
CA399908885
437 A>E No ClinGen
gnomAD
rs778907403
CA8663788
440 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA399908999
rs1393315974
442 E>G No ClinGen
gnomAD
CA8663789
rs746081603
443 G>R No ClinGen
ExAC
gnomAD
rs143346779
CA8663790
444 I>T No ClinGen
ESP
ExAC
gnomAD
rs61751971
CA399909085
448 N>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs542512687
CA8663793
450 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs372208673
CA291879370
451 Y>C No ClinGen
Ensembl
CA8663794
rs777204294
451 Y>H No ClinGen
ExAC
gnomAD
CA8663796
rs765623858
454 G>D No ClinGen
ExAC
gnomAD
CA399909170
rs1480696814
454 G>R No ClinGen
TOPMed
gnomAD
rs1480696814
CA399909168
454 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1598050555
CA399909272
460 E>G No ClinGen
Ensembl
CA399909286
rs1235326725
461 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA8663797
rs773636431
CA8663798
461 G>R No ClinGen
ExAC
gnomAD
rs1312658208
CA399909295
462 M>L No ClinGen
TOPMed
CA399909293
rs1312658208
462 M>V No ClinGen
TOPMed
CA399909330
rs1598050593
464 D>G No ClinGen
Ensembl
CA8663800
rs752159238
464 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs763880430
CA8663802
465 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1453677018
CA399909395
468 P>H No ClinGen
gnomAD
CA291879384
rs755411164
468 P>S No ClinGen
gnomAD
rs367589588
CA8663804
469 L>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663825
rs201554828
472 H>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8663826
rs747244669
472 H>R No ClinGen
ExAC
gnomAD
rs781303676
CA8663828
474 D>N No ClinGen
ExAC
gnomAD
CA399909503
rs1277885219
475 G>D No ClinGen
TOPMed
rs1598050958
CA399909522
476 L>P No ClinGen
Ensembl
CA291879475
rs374140693
476 L>V No ClinGen
ESP
gnomAD
rs549426255
CA8663831
480 V>I No ClinGen
1000Genomes
ExAC
gnomAD
CA8663833
rs771271385
481 G>A No ClinGen
ExAC
gnomAD
CA399909699
rs1175017313
483 Y>C No ClinGen
gnomAD
rs774644426
CA8663834
483 Y>H No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 486 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1345588714
CA399909815
488 C>F No ClinGen
gnomAD
CA399909842
rs1432755986
490 Q>E No ClinGen
TOPMed
gnomAD
TCGA novel 491 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8663835
rs760341635
492 Q>R No ClinGen
ExAC
gnomAD
rs1388934422
CA399909947
494 K>* No ClinGen
TOPMed
TCGA novel 495 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8663837
rs776159129
498 P>A No ClinGen
ExAC
gnomAD
rs1342368899
COSM173559
CA399910099
500 R>* large_intestine [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA8663839
rs369616072
500 R>P Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA8663838
rs369616072
500 R>Q No ClinGen
ESP
ExAC
gnomAD
CA399910121
rs1446125862
501 I>T No ClinGen
gnomAD
rs750403570
CA8663840
502 G>E No ClinGen
ExAC
gnomAD
rs1215060627
CA399910195
505 H>N No ClinGen
gnomAD
rs899909594
CA291879505
506 T>K No ClinGen
TOPMed
gnomAD
rs1490532514
CA399910272
508 R>K No ClinGen
TOPMed
gnomAD
CA399910452
rs1234870542
511 L>W No ClinGen
gnomAD
rs749789984
CA8663850
513 C>S No ClinGen
ExAC
gnomAD
CA291879630
COSM1494025
rs903103307
514 S>C kidney [Cosmic] No ClinGen
cosmic curated
Ensembl
rs771467239
CA8663851
515 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA8663852
rs546081906
516 M>I No ClinGen
1000Genomes
ExAC
gnomAD
CA291879636
rs1035375879
518 M>V No ClinGen
gnomAD
CA8663854
rs768315751
523 E>G No ClinGen
ExAC
gnomAD
CA399910646
rs1355850625
524 P>A No ClinGen
gnomAD
CA8663855
rs776153408
524 P>L No ClinGen
ExAC
gnomAD
CA8663857
rs778369845
525 W>S No ClinGen
ExAC
gnomAD
CA399910678
rs1248760741
526 A>P No ClinGen
gnomAD
rs986908475
CA291879666
530 C>G No ClinGen
TOPMed
CA8663860
rs766278449
530 C>W No ClinGen
ExAC
gnomAD
CA399910768
rs1275227484
533 T>P No ClinGen
gnomAD
rs1412591907
CA399910778
533 T>S No ClinGen
TOPMed
rs1237311840
CA399910788
534 I>M No ClinGen
gnomAD
rs1198291682
CA399910782
534 I>V No ClinGen
TOPMed
gnomAD
rs200594428
CA8663861
535 T>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs991221145
CA291879677
536 H>Q No ClinGen
TOPMed
gnomAD
CA291879674
rs958591596
536 H>Y No ClinGen
Ensembl
CA8663862
rs759251106
537 K>R No ClinGen
ExAC
gnomAD
TCGA novel 538 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1472430158
CA399910845
538 T>R No ClinGen
gnomAD
rs1264616823
CA399910859
539 H>R No ClinGen
TOPMed
gnomAD
rs1283995836
CA399910870
540 A>S No ClinGen
TOPMed
CA8663864
rs752899205
541 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs756395032
CA8663865
542 M>I No ClinGen
ExAC
gnomAD
CA399910906
rs1463697872
542 M>T No ClinGen
gnomAD
rs1454965938
CA399911026
550 T>A No ClinGen
gnomAD
rs753966757
CA8663867
551 D>G No ClinGen
ExAC
gnomAD
rs1317783301
CA399911042
551 D>N No ClinGen
TOPMed
rs149958932
CA8663868
552 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA399911123
rs1247864572
555 S>C No ClinGen
TOPMed
gnomAD
TCGA novel 555 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8663870
rs746177253
556 S>G No ClinGen
ExAC
gnomAD
CA8663871
rs758703206
556 S>T No ClinGen
ExAC
gnomAD
CA8663872
rs780529593
558 S>L No ClinGen
ExAC
TOPMed
gnomAD
CA8663874
rs561594713
560 Q>* No ClinGen
1000Genomes
ExAC
gnomAD
CA399911178
rs561594713
560 Q>K No ClinGen
1000Genomes
ExAC
gnomAD
rs61751972
RCV000395700
CA8663875
560 Q>R No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA399911235
rs1428960040
562 D>E No ClinGen
TOPMed
gnomAD
CA8663876
rs748835865
562 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA399911253
rs141588701
563 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663878
rs767939518
563 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA8663877
rs141588701
563 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8663880
rs547304654
565 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA399911346
rs1429634898
567 E>K No ClinGen
gnomAD

2 associated diseases with P52429

[MIM: 615008]: Nephrotic syndrome 7 (NPHS7)

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. NPHS7 is an autosomal recessive form characterized by onset of proteinuria usually in the first decade of life. The disorder is progressive, and some patients develop end-stage renal disease within several years. Renal biopsy typically shows membranoproliferative glomerulonephritis. {ECO:0000269|PubMed:23274426}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 615008]: Hemolytic uremic syndrome atypical 7 (AHUS7)

An atypical form of hemolytic uremic syndrome characterized by acute onset in the first year of life of microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. After the acute episode, most patients develop chronic renal insufficiency. Unlike other genetic forms of aHUS, AHUS7 is not related to abnormal activation of the complement system. {ECO:0000269|PubMed:23542698}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.

Without disease ID
  • A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. NPHS7 is an autosomal recessive form characterized by onset of proteinuria usually in the first decade of life. The disorder is progressive, and some patients develop end-stage renal disease within several years. Renal biopsy typically shows membranoproliferative glomerulonephritis. {ECO:0000269|PubMed:23274426}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • An atypical form of hemolytic uremic syndrome characterized by acute onset in the first year of life of microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. After the acute episode, most patients develop chronic renal insufficiency. Unlike other genetic forms of aHUS, AHUS7 is not related to abnormal activation of the complement system. {ECO:0000269|PubMed:23542698}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry.

4 regional properties for P52429

Type Name Position InterPro Accession
domain Diacylglycerol kinase, accessory domain 369 - 524 IPR000756
domain Diacylglycerol kinase, catalytic domain 215 - 356 IPR001206
domain Protein kinase C-like, phorbol ester/diacylglycerol-binding domain 58 - 109 IPR002219-1
domain Protein kinase C-like, phorbol ester/diacylglycerol-binding domain 124 - 177 IPR002219-2

Functions

Description
EC Number 2.7.1.107 Phosphotransferases with an alcohol group as acceptor
Subcellular Localization
  • Membrane ; Single-pass membrane protein
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
glutamatergic synapse A synapse that uses glutamate as a neurotransmitter.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
diacylglycerol kinase activity Catalysis of the reaction: NTP + 1,2-diacylglycerol = NDP + 1,2-diacylglycerol-3-phosphate.
kinase activity Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
metal ion binding Binding to a metal ion.

8 GO annotations of biological process

Name Definition
diacylglycerol metabolic process The chemical reactions and pathways involving diacylglycerol, a glyceride in which any two of the R groups (positions not specified) are acyl groups while the remaining R group can be either H or an alkyl group.
intracellular signal transduction The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
lipid phosphorylation The process of introducing one or more phosphate groups into a lipid, any member of a group of substances soluble in lipid solvents but only sparingly soluble in aqueous solvents.
modulation of chemical synaptic transmission Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission.
phosphatidic acid biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
phosphatidylinositol biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylinositol, any glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
platelet activation A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
protein kinase C-activating G protein-coupled receptor signaling pathway The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of protein kinase C (PKC). PKC is activated by second messengers including diacylglycerol (DAG).

10 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5KSL6 DGKK Diacylglycerol kinase kappa Homo sapiens (Human) PR
Q86XP1 DGKH Diacylglycerol kinase eta Homo sapiens (Human) PR
O88673 Dgka Diacylglycerol kinase alpha Mus musculus (Mouse) PR
Q6P5E8 Dgkq Diacylglycerol kinase theta Mus musculus (Mouse) PR
Q91WG7 Dgkg Diacylglycerol kinase gamma Mus musculus (Mouse) PR
P20192 DGKA Diacylglycerol kinase alpha Sus scrofa (Pig) PR
P49620 Dgkg Diacylglycerol kinase gamma Rattus norvegicus (Rat) PR
P51556 Dgka Diacylglycerol kinase alpha Rattus norvegicus (Rat) PR
Q8VZG1 DGK3 Diacylglycerol kinase 3 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FFN7 DGK2 Diacylglycerol kinase 2 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MEAERRPAPG SPSEGLFADG HLILWTLCSV LLPVFITFWC SLQRSRRQLH RRDIFRKSKH
70 80 90 100 110 120
GWRDTDLFSQ PTYCCVCAQH ILQGAFCDCC GLRVDEGCLR KADKRFQCKE IMLKNDTKVL
130 140 150 160 170 180
DAMPHHWIRG NVPLCSYCMV CKQQCGCQPK LCDYRCIWCQ KTVHDECMKN SLKNEKCDFG
190 200 210 220 230 240
EFKNLIIPPS YLTSINQMRK DKKTDYEVLA SKLGKQWTPL IILANSRSGT NMGEGLLGEF
250 260 270 280 290 300
RILLNPVQVF DVTKTPPIKA LQLCTLLPYY SARVLVCGGD GTVGWVLDAV DDMKIKGQEK
310 320 330 340 350 360
YIPQVAVLPL GTGNDLSNTL GWGTGYAGEI PVAQVLRNVM EADGIKLDRW KVQVTNKGYY
370 380 390 400 410 420
NLRKPKEFTM NNYFSVGPDA LMALNFHAHR EKAPSLFSSR ILNKAVYLFY GTKDCLVQEC
430 440 450 460 470 480
KDLNKKVELE LDGERVALPS LEGIIVLNIG YWGGGCRLWE GMGDETYPLA RHDDGLLEVV
490 500 510 520 530 540
GVYGSFHCAQ IQVKLANPFR IGQAHTVRLI LKCSMMPMQV DGEPWAQGPC TVTITHKTHA
550 560
MMLYFSGEQT DDDISSTSDQ EDIKATE